These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 18276850)

  • 1. A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence.
    Liu CI; Liu GY; Song Y; Yin F; Hensler ME; Jeng WY; Nizet V; Wang AH; Oldfield E
    Science; 2008 Mar; 319(5868):1391-4. PubMed ID: 18276850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dehydrosqualene Desaturase as a Novel Target for Anti-Virulence Therapy against
    Gao P; Davies J; Kao RYT
    mBio; 2017 Sep; 8(5):. PubMed ID: 28874472
    [No Abstract]   [Full Text] [Related]  

  • 3. Phosphonosulfonates are potent, selective inhibitors of dehydrosqualene synthase and staphyloxanthin biosynthesis in Staphylococcus aureus.
    Song Y; Lin FY; Yin F; Hensler M; Rodrígues Poveda CA; Mukkamala D; Cao R; Wang H; Morita CT; González Pacanowska D; Nizet V; Oldfield E
    J Med Chem; 2009 Feb; 52(4):976-88. PubMed ID: 19191557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Removing the golden coat of Staphylococcus aureus.
    Daum RS
    N Engl J Med; 2008 Jul; 359(1):85-7. PubMed ID: 18596277
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular docking studies to map the binding site of squalene synthase inhibitors on dehydrosqualene synthase of Staphylococcus aureus.
    Kahlon AK; Roy S; Sharma A
    J Biomol Struct Dyn; 2010 Oct; 28(2):201-10. PubMed ID: 20645653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of staphyloxanthin virulence factor biosynthesis in Staphylococcus aureus: in vitro, in vivo, and crystallographic results.
    Song Y; Liu CI; Lin FY; No JH; Hensler M; Liu YL; Jeng WY; Low J; Liu GY; Nizet V; Wang AH; Oldfield E
    J Med Chem; 2009 Jul; 52(13):3869-80. PubMed ID: 19456099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting isoprenoid biosynthesis for drug discovery: bench to bedside.
    Oldfield E
    Acc Chem Res; 2010 Sep; 43(9):1216-26. PubMed ID: 20560544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual dehydrosqualene/squalene synthase inhibitors: leads for innate immune system-based therapeutics.
    Lin FY; Zhang Y; Hensler M; Liu YL; Chow OA; Zhu W; Wang K; Pang R; Thienphrapa W; Nizet V; Oldfield E
    ChemMedChem; 2012 Apr; 7(4):561-4. PubMed ID: 22290830
    [No Abstract]   [Full Text] [Related]  

  • 9. Hesperidin inhibits biofilm formation, virulence and staphyloxanthin synthesis in methicillin resistant Staphylococcus aureus by targeting SarA and CrtM: an in vitro and in silico approach.
    Vijayakumar K; Muhilvannan S; Arun Vignesh M
    World J Microbiol Biotechnol; 2022 Jan; 38(3):44. PubMed ID: 35064842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics and molecular biology: a cholesterol-lowering drug with antibacterial properties.
    Linder MD; Ikonen E
    Curr Opin Lipidol; 2008 Jun; 19(3):324-5. PubMed ID: 18460926
    [No Abstract]   [Full Text] [Related]  

  • 11. Celastrol mitigates staphyloxanthin biosynthesis and biofilm formation in Staphylococcus aureus via targeting key regulators of virulence; in vitro and in vivo approach.
    Yehia FAA; Yousef N; Askoura M
    BMC Microbiol; 2022 Apr; 22(1):106. PubMed ID: 35421933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squalene synthase as a target for Chagas disease therapeutics.
    Shang N; Li Q; Ko TP; Chan HC; Li J; Zheng Y; Huang CH; Ren F; Chen CC; Zhu Z; Galizzi M; Li ZH; Rodrigues-Poveda CA; Gonzalez-Pacanowska D; Veiga-Santos P; de Carvalho TM; de Souza W; Urbina JA; Wang AH; Docampo R; Li K; Liu YL; Oldfield E; Guo RT
    PLoS Pathog; 2014 May; 10(5):e1004114. PubMed ID: 24789335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-molecule targeting of a diapophytoene desaturase inhibits S. aureus virulence.
    Chen F; Di H; Wang Y; Cao Q; Xu B; Zhang X; Yang N; Liu G; Yang CG; Xu Y; Jiang H; Lian F; Zhang N; Li J; Lan L
    Nat Chem Biol; 2016 Mar; 12(3):174-9. PubMed ID: 26780405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of carotenoid biosynthetic pathways using squalene synthase.
    Furubayashi M; Li L; Katabami A; Saito K; Umeno D
    FEBS Lett; 2014 Jan; 588(3):436-42. PubMed ID: 24333579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and biosynthesis of staphyloxanthin from Staphylococcus aureus.
    Pelz A; Wieland KP; Putzbach K; Hentschel P; Albert K; Götz F
    J Biol Chem; 2005 Sep; 280(37):32493-8. PubMed ID: 16020541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glyceryl trinitrate blocks staphyloxanthin and biofilm formation in
    Abbas HA; Elsherbini AM; Shaldam MA
    Afr Health Sci; 2019 Mar; 19(1):1376-1384. PubMed ID: 31148964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action and inhibition of dehydrosqualene synthase.
    Lin FY; Liu CI; Liu YL; Zhang Y; Wang K; Jeng WY; Ko TP; Cao R; Wang AH; Oldfield E
    Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21337-42. PubMed ID: 21098670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Golden pigment production and virulence gene expression are affected by metabolisms in Staphylococcus aureus.
    Lan L; Cheng A; Dunman PM; Missiakas D; He C
    J Bacteriol; 2010 Jun; 192(12):3068-77. PubMed ID: 20400547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and biochemical analyses of the biosynthesis of the yellow carotenoid 4,4'-diaponeurosporene of Staphylococcus aureus.
    Wieland B; Feil C; Gloria-Maercker E; Thumm G; Lechner M; Bravo JM; Poralla K; Götz F
    J Bacteriol; 1994 Dec; 176(24):7719-26. PubMed ID: 8002598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding modes of zaragozic acid A to human squalene synthase and staphylococcal dehydrosqualene synthase.
    Liu CI; Jeng WY; Chang WJ; Ko TP; Wang AH
    J Biol Chem; 2012 May; 287(22):18750-7. PubMed ID: 22474324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.